218 related articles for article (PubMed ID: 15240677)
1. IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21.
Moroz A; Eppolito C; Li Q; Tao J; Clegg CH; Shrikant PA
J Immunol; 2004 Jul; 173(2):900-9. PubMed ID: 15240677
[TBL] [Abstract][Full Text] [Related]
2. IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells.
Alves NL; Arosa FA; van Lier RA
J Immunol; 2005 Jul; 175(2):755-62. PubMed ID: 16002671
[TBL] [Abstract][Full Text] [Related]
3. IL-12-programmed long-term CD8+ T cell responses require STAT4.
Li Q; Eppolito C; Odunsi K; Shrikant PA
J Immunol; 2006 Dec; 177(11):7618-25. PubMed ID: 17114431
[TBL] [Abstract][Full Text] [Related]
4. Type I IFN substitutes for T cell help during viral infections.
Wiesel M; Kratky W; Oxenius A
J Immunol; 2011 Jan; 186(2):754-63. PubMed ID: 21160039
[TBL] [Abstract][Full Text] [Related]
5. The growth of the very large CD8+ T cell clones in older mice is controlled by cytokines.
Ku CC; Kappler J; Marrack P
J Immunol; 2001 Feb; 166(4):2186-93. PubMed ID: 11160271
[TBL] [Abstract][Full Text] [Related]
6. Soluble γc receptor attenuates anti-tumor responses of CD8
Kim G; Hwang H; Jo Y; Lee B; Lee YH; Kim CH; Hong C
Int J Cancer; 2018 Sep; 143(5):1212-1223. PubMed ID: 29577276
[TBL] [Abstract][Full Text] [Related]
7. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
Bristol JA; Schlom J; Abrams SI
Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883
[TBL] [Abstract][Full Text] [Related]
8. Local IL-21 promotes the therapeutic activity of effector T cells by decreasing regulatory T cells within the tumor microenvironment.
Kim-Schulze S; Kim HS; Fan Q; Kim DW; Kaufman HL
Mol Ther; 2009 Feb; 17(2):380-8. PubMed ID: 19034262
[TBL] [Abstract][Full Text] [Related]
9. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
10. IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype.
Casey KA; Mescher MF
J Immunol; 2007 Jun; 178(12):7640-8. PubMed ID: 17548600
[TBL] [Abstract][Full Text] [Related]
11. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells.
Klebanoff CA; Finkelstein SE; Surman DR; Lichtman MK; Gattinoni L; Theoret MR; Grewal N; Spiess PJ; Antony PA; Palmer DC; Tagaya Y; Rosenberg SA; Waldmann TA; Restifo NP
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1969-74. PubMed ID: 14762166
[TBL] [Abstract][Full Text] [Related]
12. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice.
Marks-Konczalik J; Dubois S; Losi JM; Sabzevari H; Yamada N; Feigenbaum L; Waldmann TA; Tagaya Y
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11445-50. PubMed ID: 11016962
[TBL] [Abstract][Full Text] [Related]
13. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.
Gattinoni L; Finkelstein SE; Klebanoff CA; Antony PA; Palmer DC; Spiess PJ; Hwang LN; Yu Z; Wrzesinski C; Heimann DM; Surh CD; Rosenberg SA; Restifo NP
J Exp Med; 2005 Oct; 202(7):907-12. PubMed ID: 16203864
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
[TBL] [Abstract][Full Text] [Related]
15. Type 1 and type 2 CD8+ effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor.
Dobrzanski MJ; Reome JB; Dutton RW
J Immunol; 2000 Jan; 164(2):916-25. PubMed ID: 10623840
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.
Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R
J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520
[TBL] [Abstract][Full Text] [Related]
17. NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.
Salagianni M; Lekka E; Moustaki A; Iliopoulou EG; Baxevanis CN; Papamichail M; Perez SA
J Immunol; 2011 Mar; 186(6):3327-35. PubMed ID: 21317394
[TBL] [Abstract][Full Text] [Related]
18. CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.
Hervas-Stubbs S; Mancheño U; Riezu-Boj JI; Larraga A; Ochoa MC; Alignani D; Alfaro C; Morales-Kastresana A; Gonzalez I; Larrea E; Pircher H; Le Bon A; Lopez-Picazo JM; Martín-Algarra S; Prieto J; Melero I
J Immunol; 2012 Oct; 189(7):3299-310. PubMed ID: 22925929
[TBL] [Abstract][Full Text] [Related]
19. Supraphysiological Levels of IL-2 in Jak3-Deficient Mice Promote Strong Proliferative Responses of Adoptively Transferred Naive CD8
Lee GW; Lee SW; Kim J; Ju YJ; Kim HO; Yun CH; Cho JH
Front Immunol; 2020; 11():616898. PubMed ID: 33584707
[TBL] [Abstract][Full Text] [Related]
20. Adoptively transferred late allergic airway responses are associated with Th2-type cytokines in the rat.
Watanabe A; Mishima H; Kotsimbos TC; Hojo M; Renzi PM; Martin JG; Hamid QA
Am J Respir Cell Mol Biol; 1997 Jan; 16(1):69-74. PubMed ID: 8998081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
